Commons Chamber
Oral Answers to Questions - Wed 20 Mar 2024
Cabinet Office

Mentions:
1: Gerald Jones (Lab - Merthyr Tydfil and Rhymney) What steps the Government are taking to help support women experiencing menopause at work. - Speech Link
2: Mims Davies (Con - Mid Sussex) In March 2023, I appointed Helen Tomlinson as the Government’s first menopause employment champion. - Speech Link
3: Gerald Jones (Lab - Merthyr Tydfil and Rhymney) the introduction of the British Standards Institution standard on menstruation, menstrual health and menopause - Speech Link

---

Select Committee

Large Print - Accessibility of products and services to disabled people

Report Mar. 19 2024

Committee: Women and Equalities Committee

Found: Strategy: Government Response to the Committee’s First ReportHC 563 Session 2022–23 Number Title Ref 1st Menopause

---

Select Committee

Kings College London, and University College London

Oral Evidence Mar. 18 2024

Inquiry: Preterm Birth
Inquiry Status: Closed
Committee: Preterm Birth Committee

Found: statement like the WHO did, which seemed to say that no woman should have a drink between menarche and menopause

---

Commons Chamber
Oral Answers to Questions - Mon 18 Mar 2024
Department for Work and Pensions

Mentions:
1: Henry Smith (Con - Crawley) I extend my gratitude to the Minister for Disabled People, Health and Work for recently holding a menopause - Speech Link
2: Mims Davies (Con - Mid Sussex) They are informing the sector work of the menopause employment champion, and her one-year report is now - Speech Link

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 1 (PDF)

Found: ion to bee sting, Crohn's disease, neuralgia, hypertensio n, diabetes, spondylit is, breast cancer, menopause

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/857 - attachment 7 (PDF)

Found: disorders Breast signs and symptoms Breast pain 2 0 Menopausal effects NEC Premature menopause

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 2 (PDF)

Found: February 2022 CONFIDENTIAL AND PROPRIETARY 243of 813Given the lack of case -level det ail surrounding menopause

---

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 8 (PDF)

Found: to EpiChron specific codes and found that many codes for dy smenorrhea , primary amenorrhea and menopause

---

Select Committee

Fourth Report - Accessibility of products and services to disabled people

Report Mar. 13 2024

Committee: Women and Equalities Committee

Found: Government Response to the Committee’s First ReportHC 563 Session 2022–23 Number Title Reference 1st Menopause

---

---